Logo image of BSBK

BOGOTA FINANCIAL CORP (BSBK) Stock Fundamental Analysis

NASDAQ:BSBK - Nasdaq - US0972351052 - Common Stock - Currency: USD

8.3999  +0.1 (+1.2%)

Fundamental Rating

2

Overall BSBK gets a fundamental rating of 2 out of 10. We evaluated BSBK against 392 industry peers in the Banks industry. BSBK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BSBK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BSBK has reported negative net income.
BSBK had a positive operating cash flow in the past year.
Of the past 5 years BSBK 4 years were profitable.
BSBK had a positive operating cash flow in 4 of the past 5 years.
BSBK Yearly Net Income VS EBIT VS OCF VS FCFBSBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

1.2 Ratios

BSBK's Return On Assets of -0.11% is on the low side compared to the rest of the industry. BSBK is outperformed by 91.58% of its industry peers.
Looking at the Return On Equity, with a value of -0.72%, BSBK is doing worse than 91.58% of the companies in the same industry.
Industry RankSector Rank
ROA -0.11%
ROE -0.72%
ROIC N/A
ROA(3y)0.19%
ROA(5y)0.35%
ROE(3y)1.27%
ROE(5y)2.1%
ROIC(3y)N/A
ROIC(5y)N/A
BSBK Yearly ROA, ROE, ROICBSBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4

1.3 Margins

BSBK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BSBK Yearly Profit, Operating, Gross MarginsBSBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

BSBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BSBK has less shares outstanding
The number of shares outstanding for BSBK has been reduced compared to 5 years ago.
BSBK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BSBK Yearly Shares OutstandingBSBK Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
BSBK Yearly Total Debt VS Total AssetsBSBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

BSBK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC12.86%
BSBK Yearly LT Debt VS Equity VS FCFBSBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BSBK Yearly Current Assets VS Current LiabilitesBSBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

BSBK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.99%.
Looking at the last year, BSBK shows a decrease in Revenue. The Revenue has decreased by -5.75% in the last year.
BSBK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.32% yearly.
EPS 1Y (TTM)-26.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%268.51%
Revenue 1Y (TTM)-5.75%
Revenue growth 3Y-20.6%
Revenue growth 5Y0.32%
Sales Q2Q%51.85%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BSBK Yearly Revenue VS EstimatesBSBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BSBK Yearly EPS VS EstimatesBSBK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 0.1 0.2 0.3 0.4 0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BSBK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BSBK Price Earnings VS Forward Price EarningsBSBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BSBK Per share dataBSBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BSBK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOGOTA FINANCIAL CORP

NASDAQ:BSBK (8/8/2025, 8:21:43 PM)

8.3999

+0.1 (+1.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-30 2025-10-30
Inst Owners7.97%
Inst Owner Change0%
Ins Owners2.64%
Ins Owner Change0.61%
Market Cap109.28M
Analysts43.33
Price TargetN/A
Short Float %0.72%
Short Ratio6.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.14
P/FCF N/A
P/OCF 358.54
P/B 0.79
P/tB 0.79
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0.02
OCFY0.28%
SpS1.03
BVpS10.63
TBVpS10.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.11%
ROE -0.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.19%
ROA(5y)0.35%
ROE(3y)1.27%
ROE(5y)2.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 77.34%
Cap/Sales 2.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC12.86%
ROIC/WACCN/A
Cap/Depr(3y)76.8%
Cap/Depr(5y)245.23%
Cap/Sales(3y)2.65%
Cap/Sales(5y)5.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%268.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.75%
Revenue growth 3Y-20.6%
Revenue growth 5Y0.32%
Sales Q2Q%51.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-101.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.12%
OCF growth 3YN/A
OCF growth 5YN/A